Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
04/2010
04/21/2010CN101695495A Composition for treatment of external secretion disorders
04/21/2010CN101695486A Use of chlorogenic acid in preparing medicament for treating marrow fibrillation
04/21/2010CN101695484A Use of chlorogenic acid in preparing medicament for treating marrow infection
04/21/2010CN101181290B Pharmaceutical composition and preparation method thereof
04/21/2010CN101011521B Chinese patent drug for nourishing liver and kidney, tranquilizing the mind and developing intelligence and its preparation method
04/20/2010USRE41253 Antineoplastic combinations
04/20/2010USRE41252 Peptidyl prodrugs and linkers and stabilizers useful therefor
04/20/2010US7700778 Acylated piperidine derivatives as melanocortin-4 receptor agonists
04/20/2010US7700761 3-deoxypentopyranosyl nucleic acid, its production and its use
04/20/2010US7700660 Method of treating chronic ulcers
04/20/2010US7700645 Comprising the ethanolate solvate of Prezista" aka darunavir ethanolate; improved pharmacokinetics;stability; bioavailability; purity; industrial scale; viricides
04/20/2010US7700635 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitorsfor seine/threonine kinases, phosphatases; Alzheimer's
04/20/2010US7700610 Use of tyrosine kinase inhibitors for treating allergic diseases
04/20/2010US7700586 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
04/20/2010US7700571 Compositions and methods for liver growth and liver protection
04/20/2010US7700562 Use of —furin—“convertase” inhibitors in the treatment of fibrosis and scarring
04/20/2010US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides
04/20/2010US7700557 for treating diseases relating to angiogenesis; fusion protein possesses ribosome inactivating activity and ability to bind to cellular vascular endothelial growth factor (VEGF) receptors
04/20/2010US7700554 Compositions for modulating blood-brain barrier transport
04/20/2010US7700361 Secretory or membrane protein expressed in skeletal muscles
04/20/2010US7700358 Transformed microorganism comprising an isolated fragment of DNA derived from coffee and integrated into the genome or plasmid of the mannase; involved in the hydrolysis of polysaccharides
04/20/2010US7700341 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
04/20/2010US7700315 Comprises nucleotide sequences coding polypeptide with serine protease activity for use in identifying modulator and treaments for blood coagulation and cell proliferative disorders
04/20/2010US7700132 Isolated material having an anti-organotrophic effect
04/20/2010US7700092 Pneumovirus NS proteins antagonize the interferon IFN response
04/20/2010US7700080 Oxidation resistance; aging resistance; skin disorders
04/20/2010US7700077 comprising from 1300 to 1500 mg/l of Na+, from 4500 to 6500 mg/l of K+, from 50 to 1300 mg/l of Mg++, from 20 to 350 mg/l of ca++, from 4000 to 6000 mg/l of Cl-, a pH of from 4-9, and an osmolality of from 150-700 mOsm/kg; for treating and cleaning the eye
04/20/2010CA2447926C Single-daily-dose antidiabetic oral pharmaceutical form comprising a biguanide and at least another active principle
04/20/2010CA2433409C Use of mglur5 antagonists for the treatment of pruritic conditions
04/20/2010CA2433335C Particles for inhalation having sustained release properties
04/20/2010CA2410579C Methods and compositions for treating flaviviruses and pestiviruses
04/20/2010CA2393159C Methods of treating tumors
04/20/2010CA2388240C Phenoxy carboxylic acid compounds and compositions for delivering active agents
04/20/2010CA2362331C Epoxide hydrolase complexes and methods therewith
04/20/2010CA2319680C Compounds and compositions for delivering active agents
04/20/2010CA2306442C Human ribonuclease a with reduced ribonuclease inhibitor affinity
04/20/2010CA2287541C Regulatory system for inducible expression of genes with lambdoid promoters
04/20/2010CA2279331C Compounds and compositions for delivering active agents
04/20/2010CA2268358C Hormonal composition consisting of an oestrogen compound and of a progestational compound
04/20/2010CA2229078C Pharmaceutical composition containing il-10
04/20/2010CA2219876C Stable variant hk2 polypeptide
04/15/2010WO2010042640A1 Use of anti-il-20 antibody for treating stroke
04/15/2010WO2010042229A2 Treatment of chronic fatigue syndrome using selective agonists of toll-like receptor 3 (tlr3)
04/15/2010WO2010041748A1 Fluorene compound and use thereof for medical purposes
04/15/2010WO2010041726A1 Substituted tricyclic heteroaryl compound
04/15/2010WO2010041703A1 Anti-sars coronavirus agent, and product containing anti-sars coronavirus agent
04/15/2010WO2010041647A1 Physical endurance improving agent, anti-fatigue agent or fatigue recovering agent comprising amino acid composition as active ingredient
04/15/2010WO2010041617A1 Fusion protein composed of matrix metalloproteinase-2 inhibitor peptide derived from amyloid-β precursor protein and tissue inhibitor of metalloproteinase-2
04/15/2010WO2010041569A1 Indazole compound
04/15/2010WO2010041568A1 Indazole derivative
04/15/2010WO2010041449A1 Anti-allergic agent comprising rxr agonist as active ingredient
04/15/2010WO2010041401A1 Protein phosphatase inhibitor
04/15/2010WO2010040305A1 Pharmaceutical being used for treating cancer and fibrosis disease and the composition and uses thereof
04/15/2010WO2010018837A3 Protein cross-linking inhibitor
04/15/2010WO2010018836A3 Polyglutamine aggregation inhibitor
04/15/2010US20100095398 Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors
04/15/2010US20100094002 Thiazole Compound and Use Thereof
04/15/2010US20100093870 Herbal medicaments for the treatment of neurocerebrovascular disorders
04/15/2010US20100093869 Sensation masking composition
04/15/2010US20100093866 Pharmaceutical Formulations
04/15/2010US20100093856 Omega-3 diglyceride emulsions
04/15/2010US20100093855 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
04/15/2010US20100093839 hypoxia-inducible factor-1 alpha (HIP-1 alpha); nucleosides, Locked Nucleic Acids; treating kidney cancer, melanoma, glioblastoma and prostate cancer, and pre-eclampsia
04/15/2010US20100093838 Regulation of angiogenesis with zinc finger proteins
04/15/2010US20100093825 Bicycloester derivative
04/15/2010US20100093821 3-Amino-pyrazole-4-carboxamide derivatives useful as inhibitors of protein kinases
04/15/2010US20100093802 Ccr9 inhibitors and methods of use thereof
04/15/2010US20100093782 Pyrazolonaphthyridine derivatives
04/15/2010US20100093746 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha. 7-nachr ligands for the treatment of cns diseases
04/15/2010US20100093732 Acid Addition Salts, Hydrates and Polymorphs of 5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic Acid Ethylamide and Formulations Comprising These Forms
04/15/2010US20100093708 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
04/15/2010US20100093690 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
04/15/2010US20100093671 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
04/15/2010US20100093662 Novel amphiphilic cyclodextrin derivatives
04/15/2010US20100093632 Enamel matrix protein composition for treatment of systemic inflammatory response
04/15/2010US20100093631 Method of treating cravings by administration of nerve growth factor
04/15/2010US20100093003 Methods to impair hematologic cancer progenitor cells and compounds related thereto
04/15/2010US20100092997 Method of Enhancing of Binding Activity of Antibody Composition to FcGamma Receptor IIIa
04/15/2010US20100092990 Nucleic acids encoding sodium channel scn1a alpha subunit proteins and mutations associated with epilepsy
04/15/2010US20100092571 Microcapsules having multiple shells and method for the preparation thereof
04/15/2010US20100092553 anti-misuse microparticulate oral pharmaceutical form
04/15/2010US20100092472 Compounds and methods for the modulation of beta-1 integrin function to mediate tissue repair
04/15/2010US20100092471 Porphyromonas Gingivalis Polypeptides Useful in the Prevention of Periodontal Disease
04/15/2010US20100092458 Regulation of apg8 phosphorylation and uses thereof
04/15/2010US20100092449 Treatment of Pompe's Disease
04/15/2010US20100092446 Drug solution having reduced dissolved oxygen content, method of producing the same and drug solution containing unit having reduced dissolved oxygen content
04/15/2010US20100092406 Systems, Methods, and Compositions for Treatment and Use of a Palatal Patch
04/15/2010CA2740772A1 Indazole compounds
04/15/2010CA2740011A1 Treatment of chronic fatigue syndrome using selective agonists of toll-like receptor 3 (tlr3)
04/14/2010EP2174958A1 Antibodies derived from anti ed-b l19 and targeting tumor vasculature
04/14/2010EP2174955A1 Ifnar2 muteins, their production and use
04/14/2010EP2174953A1 Compositions and methods for the diagnosis and treatment of tumor
04/14/2010EP2174939A1 Pyranones useful as ATM inhibitors
04/14/2010EP2174930A1 Antitumor agent comprising sulfostin and sulfostin-related compound as the active ingredient
04/14/2010EP2174666A1 Medicinal agent for prevention or treatment of alzheimer's disease
04/14/2010EP2174660A1 Composition for mucosal administration containing agent for accelerating mucosal absorption of peptide drug and administration method thereof
04/14/2010EP2174659A1 Substituted indeno[1,2-c]isoquinoline derivatives and uses thereof
04/14/2010EP1627871B1 Cyclic aminophenyl sulfamate derivative
04/14/2010EP1576089B1 Expansion of renewable stem cell populations
04/14/2010EP1507533B1 Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins
1 ... 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 ... 1564